Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS46000929BKPyvENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS10000961HBVENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS10000962HBVENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS10024388HBVENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS10026682HBVENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS10024387HBVENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS10026683HBVENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS10042402HBVENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS30010211HIVENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS30085355HIVENSG00000168959.15protein_codingGRM5NoNo2915P41594
TCGA Plot Options
Drug Information
GeneGRM5
DrugBank IDDB06201
Drug NameRufinamide
Target IDBE0001192
UniProt IDP41594
Regulation Typeinhibitor
PubMed IDs21351809
CitationsWier HA, Cerna A, So TY: Rufinamide for pediatric patients with Lennox-Gastaut syndrome: a comprehensive overview. Paediatr Drugs. 2011 Apr 1;13(2):97-106. doi: 10.2165/11586920-000000000-00000.
GroupsApproved
Direct Classification2-heteroaryl carboxamides
SMILESNC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1
Pathways
PharmGKBPA166131606
ChEMBLCHEMBL1201754